Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Moon

Showing results (951-960 of 975) with videos related to

Pageof 98
Sort By:
World Journal of Urology|October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology|June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
JACC. Cardiovascular Imaging|August 29, 2024
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort StudyHunain Shiwani, Jessica Artico, James C Moon, et al.
Iscience|June 5, 2023
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infectionMartina Milighetti, Yanchun Peng, Cedric Tan, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Circulation|May 5, 2016
Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D Gillmore, Mathew S Maurer, Rodney H Falk, et al.
BJU International|September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology|March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node statusFarshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
European Heart Journal|February 17, 2021
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonanceTushar Kotecha, Daniel S Knight, Yousuf Razvi, et al.
Pageof 98

Showing results (951-960 of 975) with videos related to

Sort By:
Pageof 98
World Journal of Urology|October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology|June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
JACC. Cardiovascular Imaging|August 29, 2024
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort StudyHunain Shiwani, Jessica Artico, James C Moon, et al.
Iscience|June 5, 2023
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infectionMartina Milighetti, Yanchun Peng, Cedric Tan, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Circulation|May 5, 2016
Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D Gillmore, Mathew S Maurer, Rodney H Falk, et al.
BJU International|September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology|March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node statusFarshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
European Heart Journal|February 17, 2021
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonanceTushar Kotecha, Daniel S Knight, Yousuf Razvi, et al.
Pageof 98